LGT Group Foundation lifted its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 2.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 148,757 shares of the technology company’s stock after buying an additional 3,802 shares during the quarter. LGT Group Foundation owned about 0.09% of Veeva Systems worth $43,624,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the stock. Jensen Investment Management Inc. grew its holdings in Veeva Systems by 1,924.5% in the 3rd quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company’s stock valued at $123,100,000 after buying an additional 392,802 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of Veeva Systems by 11.2% in the 3rd quarter. Principal Financial Group Inc. now owns 3,846,877 shares of the technology company’s stock valued at $1,146,040,000 after purchasing an additional 388,864 shares during the last quarter. Alphinity Investment Management Pty Ltd purchased a new stake in shares of Veeva Systems during the 3rd quarter valued at $422,241,000. Compass Wealth Management LLC purchased a new stake in shares of Veeva Systems during the 3rd quarter valued at $18,694,000. Finally, ABN AMRO Bank N.V. acquired a new stake in shares of Veeva Systems during the 3rd quarter worth $246,625,000. 88.20% of the stock is owned by hedge funds and other institutional investors.
Trending Headlines about Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Q4 beats and raised outlook — Veeva reported revenue of ~$836M (+16% y/y) and non?GAAP EPS of $2.06, above consensus, and provided FY27 guidance that came in ahead of some estimates, which drove the initial rally. Article Title
- Positive Sentiment: AI and product roadmap cited as growth drivers — Management emphasized “agentic” AI initiatives and CRM expansion (CRM targeted to be ~10% of revenue by 2030), positioning Veeva to capture higher?value services and offset broader software AI fears. Article Title
- Positive Sentiment: Analyst support and buy ratings remain — Several firms reaffirmed or raised ratings/targets (e.g., Stifel raised target to $245; Truist reaffirmed buy), keeping institutional sentiment constructive despite some cuts. Article Title
- Neutral Sentiment: Earnings call detail available for deeper read — The full Q4 earnings call/transcript provides color on customer uptake, AI timing and margin outlook; useful for investors who want to judge execution risk vs opportunity. Article Title
- Neutral Sentiment: Technical/volume context — Trading volume was a bit below average and the stock remains under its 50? and 200?day moving averages, which can limit near?term upside until momentum recovers. (See market data summary above.)
- Negative Sentiment: Price?target cuts and cautious notes — Multiple firms trimmed price targets (Canaccord, Piper Sandler, Needham, RBC, Wells Fargo among others) citing decelerating growth, margin pressure or to reflect model changes—these headlines trimmed upside and likely capped the post?earnings rally. Article Title
- Negative Sentiment: Ongoing AI disruption debate — Despite Veeva’s positioning, some investors remain worried about how AI will change software economics and competitive dynamics; a few analysts argue AI risk and growth normalization justify a more cautious stance. Article Title
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on Veeva Systems
Veeva Systems Trading Down 0.1%
Shares of VEEV opened at $195.89 on Monday. The business’s 50-day moving average price is $203.47 and its 200 day moving average price is $246.91. The stock has a market capitalization of $32.20 billion, a P/E ratio of 36.21, a P/E/G ratio of 1.35 and a beta of 1.09. Veeva Systems Inc. has a 1-year low of $168.13 and a 1-year high of $310.50.
Veeva Systems (NYSE:VEEV – Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Veeva Systems had a net margin of 28.44% and a return on equity of 14.11%. The company had revenue of $835.95 million during the quarter, compared to analyst estimates of $810.95 million. During the same period in the prior year, the firm earned $1.74 earnings per share. The business’s quarterly revenue was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current year.
Veeva Systems declared that its board has authorized a stock repurchase plan on Monday, January 5th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the technology company to purchase up to 5.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.
Insider Buying and Selling
In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of Veeva Systems stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider directly owned 23,204 shares in the company, valued at approximately $5,370,101.72. The trade was a 4.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 10.30% of the company’s stock.
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
See Also
- Five stocks we like better than Veeva Systems
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
